Clinical Trials List
Protocol Number88998377LYM1001
Active
2024-06-01 - 2028-12-31
Phase I
Recruiting2
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Chung Kao 無
- 蘇羿囷 Division of Hematology & Oncology
- Tung-Liang Lin 無
- 林潔 Division of Nuclear Medicine
- Hung Chang 無
- 陳建誠 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林明恩 無
- - - 無
- MEI-FANG CHENG 無
- 李思慧 無
- HSIN-AN HOU 無
- CHENG-HONG TSAI 無
- Wen-Chien Chou 無
- MING YAO 無
- Chieh-Lung Cheng 無
- Shang-Ju Wu 無
- Chien-Chin Lin 無
- 劉高郎 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
260 participants
